Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.520
-0.010 (-0.65%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Biofrontera Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 46.18 | 41.71 | 37.32 | 34.07 | 28.67 | 24.1 | |
Revenue Growth | 17.83% | 11.75% | 9.54% | 18.82% | 18.98% | 27.86% |
Cost of Revenue | 9.58 | 10.96 | 18.61 | 17.44 | 15.19 | 12.74 |
Gross Profit | 36.6 | 30.74 | 18.71 | 16.63 | 13.49 | 11.36 |
Selling, General & Admin | 39.78 | 38.37 | 33.84 | 37.9 | 35 | 25.96 |
Research & Development | 2.99 | 3.72 | 2.09 | 0.08 | - | - |
Operating Expenses | 42.77 | 42.09 | 35.92 | 37.98 | 35 | 25.96 |
Operating Income | -6.17 | -11.35 | -17.21 | -21.35 | -21.51 | -14.6 |
Interest Expense | -0.48 | -0.45 | -2.04 | -0.6 | -0.37 | -0.36 |
Interest & Investment Income | - | - | - | 0.13 | 0.18 | 0.02 |
Currency Exchange Gain (Loss) | - | - | - | -0.11 | -0.03 | - |
Other Non Operating Income (Expenses) | 0.01 | 0.59 | 1.84 | 3.04 | 16.36 | -12.65 |
EBT Excluding Unusual Items | -6.64 | -11.21 | -17.41 | -18.89 | -5.38 | -27.6 |
Merger & Restructuring Charges | - | - | - | - | - | -0.75 |
Gain (Loss) on Sale of Investments | -0 | 0 | -0.01 | -7.42 | 1.75 | - |
Gain (Loss) on Sale of Assets | 0.7 | 0.7 | - | - | - | - |
Legal Settlements | - | - | - | 6.16 | -0.87 | -11.25 |
Other Unusual Items | -0.39 | - | -0.32 | 0.03 | 3.89 | 1.94 |
Pretax Income | -6.34 | -10.51 | -17.74 | -20.12 | -0.61 | -37.66 |
Income Tax Expense | 0.03 | 0.03 | 0.02 | 0.01 | 0.03 | 0.06 |
Net Income | -6.37 | -10.54 | -17.76 | -20.13 | -0.64 | -37.71 |
Net Income to Common | -6.37 | -10.54 | -17.76 | -20.13 | -0.64 | -37.71 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 12 | 10 | 6 | 2 | 1 | 0 |
Shares Outstanding (Diluted) | 12 | 10 | 6 | 2 | 1 | 0 |
Shares Change | 49.16% | 84.40% | 256.75% | 46.29% | 140.00% | - |
EPS (Basic) | -0.54 | -1.04 | -3.22 | -13.02 | -0.61 | -85.63 |
EPS (Diluted) | -0.54 | -1.04 | -3.22 | -13.02 | -0.61 | -85.63 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.93 | -13.36 | -10.28 | -24.9 | -16.24 | -26.73 |
Free Cash Flow Per Share | -0.67 | -1.31 | -1.86 | -16.10 | -15.36 | -60.68 |
Gross Margin | 79.25% | 73.71% | 50.14% | 48.80% | 47.04% | 47.13% |
Operating Margin | -13.36% | -27.21% | -46.11% | -62.67% | -75.02% | -60.59% |
Profit Margin | -13.79% | -25.26% | -47.58% | -59.09% | -2.23% | -156.49% |
Free Cash Flow Margin | -17.17% | -32.04% | -27.54% | -73.08% | -56.63% | -110.90% |
EBITDA | -5.97 | -11.21 | -16.79 | -20.85 | -20.99 | -14.06 |
EBITDA Margin | -12.93% | -26.88% | -44.98% | -61.19% | -73.21% | -58.34% |
D&A For EBITDA | 0.2 | 0.14 | 0.42 | 0.5 | 0.52 | 0.54 |
EBIT | -6.17 | -11.35 | -17.21 | -21.35 | -21.51 | -14.6 |
EBIT Margin | -13.36% | -27.21% | -46.11% | -62.67% | -75.02% | -60.59% |
Revenue as Reported | 41.71 | 41.71 | 37.32 | 34.07 | 28.67 | 24.1 |
Advertising Expenses | - | - | - | 0.2 | 0.1 | 0.5 |